T3 · Product exporter position

Germany exports of Medicaments: containing insulin (but not containing antibiotics), for therapeutic or prophylactic uses, not packaged for retail sale (HS 300331)

See where Germany stands in medicaments: containing insulin (but not containing antibiotics), for therapeutic or prophylactic uses, not packaged for retail sale: export scale, destination breadth, market position, growth, and reported trade history.

Exporter DEUHS6 300331Latest year 2024Rapid decline

Latest exports

$8.5MLatest observed lane total

Destination markets

11Reported active markets

Three-year growth

-41.2%Annualized change

Destination HHI

2,103Destination concentration

Weighted share

75.4%Reported market position

Exporter evidence

How strong is Germany in Medicaments: containing insulin (but not containing antibiotics), for therapeutic or prophylactic uses, not packaged for retail sale?

Reported exporter totals and calculated indicators for HS 300331. Values retain their observed coverage period.

Exporter scale

Latest exports$8.5M
Current 2024 exports$568.8K
Three-year average$795.3K
Historical peak$96.5M

Market position

Active destinations11
Destination HHI2,103
Weighted share75.4%
Share change+8.6 pp

Competitiveness

Three-year growth-41.2%
Volatility1.3
Maximum drawdown39%
TrendRapid decline
MeasureValueWhat it describes
ExporterGermanyCountry represented by this profile
Latest observed exports$8.5MSum of latest observed destination-lane values
Current 2024 exports$568.8KCommon-year comparison where reported
Three-year growth-41.2%Annualized change in exporter totals
Five-year growth-51%Annualized change in exporter totals
Leading destinationUKRDestination with the largest observed export value
Leading destination share41.3%Share of observed exporter totals
Destination concentration2,103HHI across destination markets
Weighted share change+8.6 ppValue-weighted latest change in market share
Limited-history lanes74.8%Share of lanes with shorter history

Destination markets

Where does Germany sell medicaments: containing insulin (but not containing antibiotics), for therapeutic or prophylactic uses, not packaged for retail sale?

Leading destination observations ranked by reported export value, with market position and access context.

DestinationLatest exportsMarket shareGrowthAccessSignal
Ukraine$3.5M98.6%+1,426.8%FTA reportedAccelerating
Italy$1.2M94.2%-32.2%FTA reportedGrowing
Iran (Islamic Republic of)$712.7K2%+466.7%Not reportedAccelerating
USA, Puerto Rico and US Virgin Islands$577.9K81.2%+326.6%Not reportedAccelerating
Kuwait$475.3K13.1%+80.7%Not reportedAccelerating
Russia$346.5K99.8%-63.5%Not reportedGrowing
Gabon$213.8K100%+626.2%Not reportedAccelerating
Finland$211.4K99.8%-28.8%FTA reportedAccelerating
Nigeria$179.3K29.1%+573.6%Not reportedAccelerating
United Kingdom$176.4K28%+50.9%FTA reportedAccelerating

Destination

Ukraine

Latest exports
$3.5M
Market share
98.6%
Growth
+1,426.8%
Access
FTA reported
Signal
Accelerating

Destination

Italy

Latest exports
$1.2M
Market share
94.2%
Growth
-32.2%
Access
FTA reported
Signal
Growing

Destination

Iran (Islamic Republic of)

Latest exports
$712.7K
Market share
2%
Growth
+466.7%
Access
Not reported
Signal
Accelerating

Destination

USA, Puerto Rico and US Virgin Islands

Latest exports
$577.9K
Market share
81.2%
Growth
+326.6%
Access
Not reported
Signal
Accelerating

Destination

Kuwait

Latest exports
$475.3K
Market share
13.1%
Growth
+80.7%
Access
Not reported
Signal
Accelerating

Destination

Russia

Latest exports
$346.5K
Market share
99.8%
Growth
-63.5%
Access
Not reported
Signal
Growing

Destination

Gabon

Latest exports
$213.8K
Market share
100%
Growth
+626.2%
Access
Not reported
Signal
Accelerating

Destination

Finland

Latest exports
$211.4K
Market share
99.8%
Growth
-28.8%
Access
FTA reported
Signal
Accelerating

Destination

Nigeria

Latest exports
$179.3K
Market share
29.1%
Growth
+573.6%
Access
Not reported
Signal
Accelerating

Destination

United Kingdom

Latest exports
$176.4K
Market share
28%
Growth
+50.9%
Access
FTA reported
Signal
Accelerating

Price intelligence

How does Germany's price position vary?

Price comparisons are shown where market-level unit-value observations are available. They describe reported trade values and quantities, not quoted selling prices.

Highest reported price

Switzerland, Liechtenstein: $6.5M / ton.

Lowest reported price

Congo, Rep. of the: $2.4K / ton.

Median price

$177.7K / ton across reported markets.

Export trend

Reported export history

Annual observations for Germany and HS 300331 where available.

YearExportsYear-on-year changeActive destinations
2010$8.7M-3.7%16
2011$17.9M+105%13
2012$73.0M+307.5%9
2013$78.1M+7%10
2014$12.9M-83.4%12
2015$12.4M-4.2%10
2016$28.8M+132.4%11
2017$26.2M-9%10
2018$60.7M+131.4%11
2019$20.1M-66.9%11
2020$7.3M-63.7%11
2021$2.8M-61.6%8
2022$1.1M-61.7%10
2023$746.6K-30.3%9
2024$568.8K-23.8%11

Exporter context

Germany economy and trade network

The exporter profile adds country-level trade and structural context to the selected product position. These indicators describe the country overall and are not limited to HS 300331.

Germany has reported exports of $1.6T and a trade balance of $239.2B in 2024.

Available structural indicators include 64.1% trade openness, 22.1% investment, and 1,080 active trade partners.

Reported values

Export totals and destination values describe reported merchandise trade for the stated exporter, HS6 classification, and available year.

Calculated indicators

Growth, concentration, weighted share, volatility, drawdown, and price comparisons are calculated from reported observations.

Coverage

Missing values remain “Not reported”. Country-level indicators are presented separately from product-level observations.

Frequently asked questions

Questions about Germany medicaments: containing insulin (but not containing antibiotics), for therapeutic or prophylactic uses, not packaged for retail sale exports

Quick answers based on the figures and coverage shown on this page.

How strong is this exporter?

Use latest exports, destination breadth, growth, concentration, and weighted share together rather than relying on one measure.

Which markets are most important?

The destination table ranks reported markets by the latest observed export value.

Does the price section show quotes?

No. It summarizes reported trade value and quantity observations converted to unit values.

What should be checked next?

Compare this exporter with buyer markets, corridors, and the product overview before making a commercial decision.